Skip to Main content Skip to Navigation
New interface
Journal articles

Amikacin pharmacokinetic/pharmacodynamic in intensive care unit: a prospective database

Abstract : Background: Aminoglycosides have a concentration-dependent therapeutic effect when peak serum concentration (C max) reaches eight to tenfold the minimal inhibitory concentration (MIC). With an amikacin MIC of 8 mg/L, the C max should be 64-80 mg/L. This objective is based on clinical breakpoints and not on measured MIC. This study aimed to assess the proportion of patients achieving the pharmacokinetic/pharmacodynamic (PK/PD) target C max /MIC ≥ 8 using the measured MIC in critically ill patients treated for documented Gram-negative bacilli (GNB) infections. Methods: Retrospective analysis from February 2016 to December 2017 of a prospective database conducted in 2 intensive care units (ICU). All patients with documented severe GNB infections treated with amikacin (single daily dose of 25 mg/kg of total body weight (TBW)) with both MIC and C max measurements at first day of treatment (D1) were included. Results are expressed in n (%) or median [min-max]. Results: 93 patients with 98 GNB-documented infections were included. The median C max was 55.2 mg/L [12.2-165.7] and the median MIC was 2 mg/L [0.19-16]. C max /MIC ratio ≥ 8 was achieved in 87 patients (88.8%) while a C max ≥ 64 mg/L was achieved in only 38 patients (38.7%). Overall probability of PK/PD target attainment was 93%. No correlation was found between C max /MIC ratio and clinical outcome at D8 and D28. Conclusion: According to PK/PD parameters observed in our study, single daily dose of amikacin 25 mg/kg of TBW appears to be sufficient in most critically ill patients treated for severe GNB infections.
Document type :
Journal articles
Complete list of metadata

Cited literature [26 references]  Display  Hide  Download
Contributor : Réunion Univ Connect in order to contact the contributor
Submitted on : Friday, November 13, 2020 - 10:42:50 AM
Last modification on : Friday, August 5, 2022 - 12:00:33 PM
Long-term archiving on: : Sunday, February 14, 2021 - 6:30:08 PM


Publication funded by an institution


Distributed under a Creative Commons Attribution 4.0 International License



Elsa Logre, Maya Enser, Sébastien Tanaka, Marie Dubert, Aurore Claudinon, et al.. Amikacin pharmacokinetic/pharmacodynamic in intensive care unit: a prospective database. Annals of Intensive Care, 2020, 10, pp.75. ⟨10.1186/s13613-020-00685-5⟩. ⟨hal-03003316⟩



Record views


Files downloads